Proton Pump Inhibitors are Risk Factors for Viral Infections: Even for COVID-19?

During the ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more attention should be paid to the balance of risks and benefits associated with proton pump inhibitors for the following reasons. One of the main functions of gastric juice is to inactivate swallowed micr...

Descripción completa

Detalles Bibliográficos
Autores principales: Charpiat, Bruno, Bleyzac, Nathalie, Tod, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417108/
https://www.ncbi.nlm.nih.gov/pubmed/32779119
http://dx.doi.org/10.1007/s40261-020-00963-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417108/
https://www.ncbi.nlm.nih.gov/pubmed/32779119
http://dx.doi.org/10.1007/s40261-020-00963-x

Ejemplares similares